Logos Capital
Healthcare and biotechnology investment managerSan Francisco, USASee on the maplogoscapital.com
Health specialist
Logos Capital is an investment firm focused on biotechnology. It invests in private and public companies developing therapeutics and healthcare innovations.
- 2
- Portfolio companies on reccy
- 1
- Hiring now
- 20
- Open roles in the portfolio
- Apr 2026
- Latest portfolio round
Hiring now in the portfolio20
Apply on each company's site- Posted 1d ago
Director, Alliance Management
Beacon Biosignals · New York, NY
- Posted 1d ago
Quality Engineer
Beacon Biosignals · Boston, MA / Remote
- Posted 1d ago
Marketing Coordinator
Beacon Biosignals · Boston, MA / Remote
- Posted 3d ago
Senior Mobile App Engineer (React Native)
Beacon Biosignals · Boston, MA / Remote
- Posted 5d ago
Business Development Associate
Beacon Biosignals · Boston, MA / Remote
- Posted 5d ago
Logistics & Distribution Manager
Beacon Biosignals · Boston, MA / Remote
- Posted 8d ago
Senior IT Specialist
Beacon Biosignals · Boston, MA / Remote
- Posted 8d ago
Fulfillment Automation Solutions Engineer
Beacon Biosignals · Boston, MA / Remote
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- Beacon BiosignalsBoston, Massachusetts
EEG and neural monitoring · Wearables
- Apr 2026Series B · $11MLed
- Nov 2025Series B · $86MLed
- Nov 2021Series A · $27M
- Jun 2019Seed · $3M
- LeonaBioBothell, Washington, United States
- Dec 2025Post-IPO Equity · $90M
- Jan 2021Post-IPO Equity · $104M
- Dec 2020Grant · $15M
- Sep 2020Convertible Note
- Jun 2020Series B · $85M
- Jun 2020Unknown · $90.9MLed
Rounds marked Led list Logos Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Apr 2026
Beacon Biosignals · Series B $11MLead
With Palo Santo Fund, JSL Health Capital, Palo Santo VC, Kicker Ventures, Samsung Next, Innoviva, Google Ventures, S32, Catalio Capital Management, General Catalyst, Casdin Capital, Indicator Ventures
- Nov 2025
Beacon Biosignals · Series B $86MLead
With Catalio Capital Management, Google Ventures, Innoviva, S32, Takeda, General Catalyst, Casdin Capital, Indicator Ventures
- Jun 2020
LeonaBio · Unknown $90.9MLead
With Ditch Plains Capital Management
Portfolio in the news
From the Cortex · last 12 months- Oct 2026Beacon Biosignals Acquires Snap to Expand Home EEG Testing
Beacon Biosignals · Articles | Neurofounders
- Oct 2026Beacon Biosignals Acquires Snap Diagnostics
Beacon Biosignals · Sleep Review
- Oct 2026
- Oct 2026